Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications
- PMID: 20173103
- DOI: 10.1148/radiol.09091406
Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications
Abstract
Purpose: To determine if patients with fewer than three foci of atypical ductal hyperplasia (ADH) who have all of their calcifications removed after stereotactic 9- or 11-gauge vacuum-assisted breast biopsy (VABB) have a rate of upgrade to malignancy that is sufficiently low to obviate surgical excision.
Materials and methods: An institutional review board-approved, HIPAA-compliant retrospective review of 991 cases of consecutive 9- or 11-gauge stereotactic VABB performed during a 65-month period revealed 147 cases of atypia. One pathologist performed a blinded review of the results of procedures performed to assess for calcifications and confirmed ADH in 101 cases with subsequent surgical excision. Each large duct or terminal duct-lobular unit containing ADH was considered a focus and counted. Postbiopsy mammograms were reviewed to determine whether all calcifications were removed. Upgrade to malignancy was determined from excisional biopsy pathology reports. Upgrade rates as a function of both number of foci and presence or absence of residual calcifications were calculated and compared by using chi(2) tests.
Results: Upgrade to malignancy occurred in 20 (19.8%) of the 101 cases. The upgrade rate was significantly higher in cases of three or more foci of ADH (15 [28%] of 53 cases) than in cases of fewer than three foci (five [10%] of 48 cases) (P = .02). Upgrade rates were similar, regardless of whether all mammographic calcifications were removed (seven [17%] of 41 cases) or all were not removed (nine [20%] of 45 cases) (P = .77). Upgrade occurred in two (12%) of 17 cases in which there were fewer than three ADH foci and all calcifications were removed.
Conclusion: The upgrade rate is significantly higher when ADH involves at least three foci. Surgical excision is recommended even when ADH involves fewer than three foci and all mammographic calcifications have been removed, because the upgrade rate is 12%.
Copyright RSNA, 2010
Comment in
-
Identifying patients with atypical ductal hyperplasia diagnosed at core-needle biopsy who are at low risk of malignancy.Radiology. 2010 Dec;257(3):893-4; author reply 984. doi: 10.1148/radiol.101253. Radiology. 2010. PMID: 21084420 No abstract available.
Similar articles
-
Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge.AJR Am J Roentgenol. 2009 Jan;192(1):229-34. doi: 10.2214/AJR.08.1342. AJR Am J Roentgenol. 2009. PMID: 19098204
-
Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy.Radiology. 1998 Jul;208(1):251-60. doi: 10.1148/radiology.208.1.9646821. Radiology. 1998. PMID: 9646821
-
Is the upgrade rate of atypical ductal hyperplasia diagnosed by core needle biopsy of calcifications different for digital and film-screen mammography?AJR Am J Roentgenol. 2014 Oct;203(4):917-22. doi: 10.2214/AJR.13.11862. AJR Am J Roentgenol. 2014. PMID: 25247961
-
Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.Breast Cancer Res Treat. 2017 Jul;164(2):295-304. doi: 10.1007/s10549-017-4253-1. Epub 2017 May 4. Breast Cancer Res Treat. 2017. PMID: 28474262 Review.
-
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?Eur Radiol. 2021 Feb;31(2):920-927. doi: 10.1007/s00330-020-07161-5. Epub 2020 Aug 20. Eur Radiol. 2021. PMID: 32816199 Review.
Cited by
-
Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.Mod Pathol. 2016 Dec;29(12):1471-1484. doi: 10.1038/modpathol.2016.127. Epub 2016 Aug 19. Mod Pathol. 2016. PMID: 27538687 Review.
-
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.Breast Cancer Res Treat. 2021 Feb;185(3):573-581. doi: 10.1007/s10549-020-05977-9. Epub 2020 Oct 17. Breast Cancer Res Treat. 2021. PMID: 33068196
-
Vacuum-assisted stereotactic breast biopsy in the diagnosis and management of suspicious microcalcifications.Diagn Interv Radiol. 2016 Jul-Aug;22(4):326-33. doi: 10.5152/dir.2015.14522. Diagn Interv Radiol. 2016. PMID: 27306660 Free PMC article.
-
Atypical hyperplasia of the breast--risk assessment and management options.N Engl J Med. 2015 Jan 1;372(1):78-89. doi: 10.1056/NEJMsr1407164. N Engl J Med. 2015. PMID: 25551530 Free PMC article. No abstract available.
-
Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens.Breast Cancer. 2019 Jul;26(4):452-458. doi: 10.1007/s12282-018-00943-2. Epub 2018 Dec 27. Breast Cancer. 2019. PMID: 30591993 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical